Liposoma BV was founded in 2013 by Asha van Rooijen. Our company provides liposomal formulations, specifically clodronate liposomes, control (PBS) liposomes and fluorescent DiI and DiO liposomes. Our team of specialist and supporting staff has successfully served thousands of research groups worldwide, in studying various models of autoimmune diseases, transplantation, neurological disorders and gene therapy. Liposoma is supported by Nico van Rooijen, who developed clodronate liposomes and has extensive knowledge and experience in consulting on the application of clodronate liposomes.

With more than 30 years experience in developing various liposomal formulations we provide high-quality products at lower costs than our competitors. Our extensive knowledge in developing liposomal formulations enables us to consult our customers effectively in the application of our products during experiments and to actively run R&D projects in order to develop new liposomal formulations to improve and extend research opportunities for our customers.